Weiqiong Zuo

602 citations

21 papers · 522 indexed · h-index 14

Co-authors: Ningyu Wang Luoting Yu Cuiting Peng Ying Xu Yongxia Zhu Xinyu You Tinghong Ye Lidan Zhang
Topics: Protein Degradation and Inhibitors (6 papers)Quinazolinone synthesis and applications (4 papers)Cancer therapeutics and mechanisms (4 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Scientific Reports Journal of Medicinal Chemistry Biochemical Pharmacology
Partner nations: China United States

In The Last Decade

Weiqiong Zuo

21 papers receiving 517 citations

Peers

Countries citing papers authored by Weiqiong Zuo

Since Specialization

Citations

This map shows the geographic impact of Weiqiong Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiong Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiong Zuo more than expected).

Fields of papers citing papers by Weiqiong Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqiong Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiong Zuo. The network helps show where Weiqiong Zuo may publish in the future.

Co-authorship network of co-authors of Weiqiong Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqiong Zuo. A scholar is included among the top collaborators of Weiqiong Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqiong Zuo. Weiqiong Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor 2021 ·European Journal of Medicinal Chemistry ·Rong Hu,Wanli Wang,(unknown),(unknown),Qiwei Wang,Weiqiong Zuo,Ying Xu,Qiang Feng,Ningyu Wang	37
2	BRD4 inhibition sensitizes aggressive non-Hodgkin lymphomas to PI3Kδ inhibitors by suppressing PI3K reactivation and c-MYC expression. 2021 ·American Journal of Cancer Research ·Weiqiong Zuo,Yongxia Zhu,Zhihao Liu,Yong Xia,Ying Xu,Cuiting Peng,Luoting Yu,Ningyu Wang	3
3	Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·Ningyu Wang,Weiqiong Zuo,Rong Hu,Wanli Wang,Yongxia Zhu,Ying Xu,Luoting Yu,Zhihao Liu	4
4	Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors 2020 ·European Journal of Medicinal Chemistry ·Ningyu Wang,Ying Xu,(unknown),Weiqiong Zuo,Yongxia Zhu,Rong Hu,Wanli Wang,Yao Shi,Luoting Yu,Zhihao Liu	34
5	Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma 2020 ·Bioorganic Chemistry ·Weiqiong Zuo,Rong Hu,(unknown),Yongxia Zhu,Ying Xu,Luoting Yu,Zhihao Liu,Ningyu Wang	9
6	Novel Dual BET and PLK1 Inhibitor WNY0824 Exerts Potent Antitumor Effects in CRPC by Inhibiting Transcription Factor Function and Inducing Mitotic Abnormality 2020 ·Molecular Cancer Therapeutics ·Ying Xu,(unknown),(unknown),Zhihao Liu,Lifeng Zhao,Xuejiao Song,Xi Hu,Zhanzhan Feng,Tiantao Gao,Weiqiong Zuo,Jun Zeng,Ningyu Wang,Luoting Yu	16
7	Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway 2019 ·Biochemical Pharmacology ·Yongxia Zhu,Weiqiong Zuo,Lijuan Chen,(unknown),(unknown),(unknown),Xiuli Wu,Hongyao Liu,(unknown),Wanglai Hu,Yuqi Guo,Yue Wang,Tinghong Ye	36
8	Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis 2019 ·Biomedicine & Pharmacotherapy ·Qiang Xue,Zhihao Liu,Zhanzhan Feng,Ying Xu,Weiqiong Zuo,Qianqian Wang,Tiantao Gao,Jun Zeng,Xi Hu,(unknown),Yongxia Zhu,Yong Xia,Luoting Yu	23
9	Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis 2018 ·Cancer Letters ·Tiantao Gao,(unknown),Xi Hu,Qian Lei,Zhanzhan Feng,Xi Yu,Cuiting Peng,Xuejiao Song,(unknown),Ying Xu,Weiqiong Zuo,Jun Zeng,Zhihao Liu,Luoting Yu	32
10	A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumors 2016 ·Biomedicine & Pharmacotherapy ·Hongxia Deng,Jun Zeng,Yongxia Zhu,Tinghong Ye,Yong Xia,Yao Shi,Ningyu Wang,Lidan Zhang,Xuejiao Song,Weiqiong Zuo,Tiantao Gao,Luoting Yu	1
11	Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma 2016 ·Scientific Reports ·Yongxia Zhu,Tinghong Ye,Xi Yu,Qian Lei,Fangfang Yang,Yong Xia,Xuejiao Song,Li Liu,Hongxia Deng,Tiantao Gao,Cuiting Peng,Weiqiong Zuo,Ying Xiong,Lidan Zhang,Ningyu Wang,Lifeng Zhao,Yongmei Xie,Luoting Yu,Yuquan Wei	64
12	Synthesis and biological evaluation of N-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzenesulfonamide derivatives as new BET bromodomain inhibitors for anti-hematologic malignancies activities 2016 ·Molecular Diversity ·Li Liu,Yongxia Zhu,Zhihao Liu,Tinghong Ye,Weiqiong Zuo,Cuiting Peng,(unknown),Ningyu Wang,Luoting Yu	2
13	Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis 2016 ·Scientific Reports ·(unknown),Cuiting Peng,Yao Shi,Xinyu You,(unknown),Lu Xiong,Tinghong Ye,Lidan Zhang,Ningyu Wang,Yongxia Zhu,Kun Liu,Weiqiong Zuo,Luoting Yu,Yuquan Wei	39
14	A new series of HCV inhibitors based on a 2-(thieno[2,3b]pyridin-2-yl)-1,3,4-oxadiazole scaffold 2016 ·RSC Advances ·Weiqiong Zuo,Ningyu Wang,Yongxia Zhu,Li Liu,(unknown),Lidan Zhang,Chao Gao,Zhihao Liu,Xinyu You,Yao Shi,Cuiting Peng,(unknown),Hong Tang,Luoting Yu	14
15	ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth 2016 ·RSC Advances ·Tiantao Gao,Lidan Zhang,Yongxia Zhu,Xuejiao Song,Qiang Feng,Qian Lei,(unknown),Hongxia Deng,Menghua Xiong,Xinyu You,Weiqiong Zuo,Li Liu,Cuiting Peng,Ningyu Wang,Tinghong Ye,Yong Xia,Luoting Yu	10
16	Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives 2015 ·Bioorganic & Medicinal Chemistry Letters ·Cuiting Peng,(unknown),Ningyu Wang,Xinyu You,Lidan Zhang,Yongxia Zhu,(unknown),Weiqiong Zuo,(unknown),Hongxia Deng,Qian Lei,(unknown),Luoting Yu	41
17	Discovery of novel N-(5-(tert-butyl)isoxazol-3-yl)-N′-phenylurea analogs as potent FLT3 inhibitors and evaluation of their activity against acute myeloid leukemia in vitro and in vivo 2015 ·Bioorganic & Medicinal Chemistry ·Ying Xu,Ningyu Wang,Xuejiao Song,Qian Lei,Tinghong Ye,Xinyu You,Weiqiong Zuo,Yong Xia,Lidan Zhang,Luoting Yu	17
18	Discovery of Imidazo[2,1-b]thiazole HCV NS4B Inhibitors Exhibiting Synergistic Effect with Other Direct-Acting Antiviral Agents 2015 ·Journal of Medicinal Chemistry ·Ningyu Wang,Ying Xu,Weiqiong Zuo,(unknown),Li Liu,(unknown),Xinyu You,Lidan Zhang,Chao Gao,Zhihao Liu,Tinghong Ye,Yong Xia,Ying Xiong,Xuejiao Song,Qian Lei,Cuiting Peng,Hong Tang,Shengyong Yang,Yuquan Wei,Luoting Yu	37
19	Discovery and structure–activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Ningyu Wang,Weiqiong Zuo,Ying Xu,Chao Gao,(unknown),Lidan Zhang,Xinyu You,Cuiting Peng,Yang Shen,Shengyong Yang,Yuquan Wei,Luoting Yu	45
20	Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents 2013 ·Bioorganic & Medicinal Chemistry Letters ·Chao Gao,Tinghong Ye,Ningyu Wang,(unknown),Lidan Zhang,Ying Xiong,Xinyu You,Yong Xia,Ying Xu,Cuiting Peng,Weiqiong Zuo,Yuquan Wei,Luoting Yu	56

About Weiqiong Zuo

Weiqiong Zuo is a scholar working on Hepatology, Hematology and Infectious Diseases, having authored 21 papers that have together received 522 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Quinazolinone synthesis and applications (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Toxicology (23 citations), Organic Chemistry (181 citations) and Molecular Biology (316 citations). Weiqiong Zuo has collaborated with scholars based in China and United States. Frequent co-authors include Ningyu Wang, Luoting Yu, Cuiting Peng, Ying Xu, Yongxia Zhu, Xinyu You, Tinghong Ye, Lidan Zhang, Yuquan Wei and Zhihao Liu. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact